We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.7B
AUM Growth
+$324M
Cap. Flow
+$89.7M
Cap. Flow %
1.91%
Top 10 Hldgs %
19.97%
Holding
310
New
46
Increased
81
Reduced
90
Closed
45

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$174M
2
ACM icon
Aecom
ACM
+$34M
3
AAPL icon
Apple
AAPL
+$33.1M
4
IMO icon
Imperial Oil
IMO
+$29.7M
5
COR icon
Cencora
COR
+$26.5M

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$47.9M
2
UPS icon
United Parcel Service
UPS
+$41.2M
3
GILD icon
Gilead Sciences
GILD
+$33M
4
MAT icon
Mattel
MAT
+$29.3M
5
TMO icon
Thermo Fisher Scientific
TMO
+$29M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Financials 21.45%
3 Healthcare 19.48%
4 Communication Services 10.66%
5 Consumer Discretionary 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
226
Amgen
AMGN
$203B
$809K 0.02%
6,836
+2,928
+75% +$339K
SWH
227
DELISTED
Stanley Black & Decker, Inc.
SWH
$709K 0.02%
+6,200
New +$693K
GILD icon
228
Gilead Sciences
GILD
$161B
$698K 0.01%
8,414
-424,124
-98% -$33M
BIIB icon
229
Biogen
BIIB
$29.9B
$538K 0.01%
1,706
-286
-14% -$86.1K
CPHD
230
DELISTED
Cepheid Inc
CPHD
$440K 0.01%
9,181
-329,482
-97% -$14.9M
MET icon
231
MetLife
MET
$61B
$416K 0.01%
8,393
– –
BMRN icon
232
BioMarin Pharmaceuticals
BMRN
$11.5B
$390K 0.01%
+6,264
New +$378K
JAZZ icon
233
Jazz Pharmaceuticals
JAZZ
$15.9B
$368K 0.01%
+2,504
New +$347K
LAB icon
234
Standard BioTools
LAB
$326M
$348K 0.01%
+11,836
New +$379K
QIWI
235
DELISTED
QIWI PLC
QIWI
$342K 0.01%
8,470
+2,300
+37% +$84.1K
INFI
236
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$321K 0.01%
25,234
+7,510
+42% +$78.2K
IONS icon
237
Ionis Pharmaceuticals
IONS
$9.35B
$310K 0.01%
+8,994
New +$283K
ALNY icon
238
Alnylam Pharmaceuticals
ALNY
$36.3B
$301K 0.01%
+4,758
New +$283K
CMRX
239
DELISTED
Chimerix, Inc.
CMRX
$294K 0.01%
+13,404
New +$266K
PB icon
240
Prosperity Bancshares
PB
$8.77B
$292K 0.01%
4,671
– –
TCBI icon
241
Texas Capital Bancshares
TCBI
$4.31B
$238K 0.01%
4,405
– –
OREX
242
DELISTED
Orexigen Therapeutics, Inc.
OREX
$191K ﹤0.01%
3,084
+774
+34% +$45K
OXFD
243
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$175K ﹤0.01%
+10,389
New +$187K
SGYP
244
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$77K ﹤0.01%
+18,947
New +$80.5K
ADSK icon
245
Autodesk
ADSK
$44.3B
– –
-47,426
Closed -$2.33M
ALGN icon
246
Align Technology
ALGN
$12B
– –
-330,000
Closed -$17.1M
AMG icon
247
Affiliated Managers Group
AMG
$9.46B
– –
-17,113
Closed -$3.42M
AVGO icon
248
Broadcom
AVGO
$1.82T
– –
-803,790
Closed -$5.17M
BKNG icon
249
Booking.com
BKNG
$138B
– –
-133,000
Closed -$6.34M
BRKR icon
250
Bruker
BRKR
$9.2B
– –
-703,410
Closed -$16M
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Polar Capital held 310 positions worth $4.7B, up 7.4% from $4.38B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Polar Capital's Q2 2014 filing shows 46 new, 81 increased, 90 reduced and 45 closed positions. Its largest new stake was Alphabet (Google) Class C: 6,402,069 shares worth $185M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $47.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q2 2014 buy was Alphabet (Google) Class C: 6,402,069 shares worth $185M.
  • Polar Capital added most to Apple in Q2 2014, an estimated $33.1M increase.
  • Polar Capital's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $47.9M.
  • Polar Capital fully exited United Parcel Service in Q2 2014, selling an estimated $41.2M.
  • Polar Capital's ten largest holdings make up 20% of its $4.7B portfolio in Q2 2014.
  • Polar Capital opened 46 new positions and closed 45 in Q2 2014.
  • Polar Capital's portfolio value rose 7.4% quarter-over-quarter to $4.7B.

Based on Polar Capital's 13F filing for Q2 2014, filed 12 Aug 2014.